MARKET

MRNA

MRNA

Moderna
NASDAQ
31.12
-1.00
-3.11%
After Hours: 31.20 +0.08 +0.26% 19:59 03/28 EDT
OPEN
32.04
PREV CLOSE
32.12
HIGH
32.50
LOW
31.02
VOLUME
5.70M
TURNOVER
--
52 WEEK HIGH
170.47
52 WEEK LOW
29.25
MARKET CAP
12.03B
P/E (TTM)
-3.3558
1D
5D
1M
3M
1Y
5Y
1D
Arbutus Biopharma: A Wing And A Prayer
Seeking Alpha · 1d ago
MRNA May 9th Options Begin Trading
NASDAQ · 1d ago
RFK Jr. reportedly plans 10,000 job cuts in HHS with FDA, CDC, Medicare affected
Seeking Alpha · 2d ago
Citi Keeps Their Hold Rating on Moderna (MRNA)
TipRanks · 2d ago
Trump administration cancels $12 billion in funding to state health departments
Seeking Alpha · 2d ago
Moderna Inc. Stock Slips 7.0%, Underperforms Competitors
Dow Jones · 2d ago
As Vaccine Skepticism Mounts, Moderna's Business Grows More Precarious
Barron‘s · 2d ago
Moderna, Novavax Shares Are Sliding Wednesday: What's Going On?
Benzinga · 2d ago
More
About MRNA
More
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. The Company’s diverse development pipeline consists of 44 therapeutic and vaccine programs, 11 of which are in late-stage development. Its commercial products include Spikevax (its COVID vaccine) and mRESVIA (its respiratory syncytial virus (RSV) vaccine). Additionally, it has achieved four positive Phase III data readouts for its COVID vaccine (mRNA-1283), its RSV vaccine for high-risk adults aged 18 to 59 (mRNA-1345), its seasonal flu+COVID vaccine (mRNA-1083), and its seasonal flu vaccine (mRNA-1010).
Recently
Symbol
Price
%Change

Webull offers Moderna Inc stock information, including NASDAQ: MRNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MRNA stock methods without spending real money on the virtual paper trading platform.